Pretransplant Induction Regimens for Multiple Myeloma

被引:1
|
作者
Vesole, David H. [1 ]
Siegel, David S. [1 ]
机构
[1] Hackensack UMC, Hackensack, NJ 07601 USA
关键词
STEM-CELL TRANSPLANTATION; DISEASE; SINGLE;
D O I
10.1016/j.bbmt.2014.12.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:200 / 201
页数:2
相关论文
共 50 条
  • [41] Evolution of Treatment Regimens in Multiple Myeloma: A Social Network Analysis
    Mahony, Helen
    Tsalatsanis, Athanasios
    Kumar, Ambuj
    Djulbegovic, Benjamin
    PLOS ONE, 2014, 9 (08):
  • [42] Effect of different therapeutic regimens on the elderly patients with multiple myeloma
    Ge, Chen
    Cao, Peng
    Xu, Xiang-yang
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (10): : 4421 - 4424
  • [43] Comparison of Maintenance Therapy Regimens of Patients Treated for Multiple Myeloma
    Wani, Kashmira
    Gutta, Radhika
    Mittal, Aayush
    Jamil, Maria
    Springer, Kylie
    Kuriakose, Philip
    BLOOD, 2023, 142
  • [44] Efficacy of regimens VAD and HyperCVAD in multiple myeloma III stage
    Stepanova, NV
    Yakubovich, MA
    Moiseev, SI
    BONE MARROW TRANSPLANTATION, 2006, 37 : S144 - S144
  • [45] A systematic review of economic evaluations of treatment regimens in multiple myeloma
    Asrar, Mir Mahmood
    Lad, Deepesh P.
    Prinja, Shankar
    Bansal, Dipika
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (04) : 799 - 809
  • [46] Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients
    Sauer, Sandra
    Hieke, Lennart
    Brandt, Julia
    Mueller-Tidow, Carsten
    Schmitt, Anita
    Kauer, Joseph
    Kriegsmann, Katharina
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (05) : 382 - 394
  • [47] Maintenance regimens after a second autologous transplant for multiple myeloma
    Mohyuddin, Ghulam Rehman
    Okoniewski, Maire
    Diab, Osama
    Ganguly, Siddhartha
    Shune, Leyla
    Abdallah, Al-Ola
    McGuirk, Joseph
    McClune, Brian
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 758 - 760
  • [48] Response Adapted Induction Therapy for Multiple Myeloma
    Valent, Jason
    Samaras, Christy
    Hastings, Debbie
    Faiman, Beth M.
    Hamilton, Kimberly
    Bolwell, Brian J.
    Reed, Janice
    Karam, Mary Ann
    Cummings, Chad
    Tullio, Katherine
    Smith, Mitchell R.
    Liu, Hien K.
    Reu, Frederic J.
    BLOOD, 2015, 126 (23)
  • [49] HEMATOLOGY Bortezomib and dexamethasone induction for multiple myeloma
    Laubach, Jacob
    Richardson, Paul
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (01) : 8 - 10
  • [50] Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma
    Vij, Ravi
    Kumar, Shaji
    Zhang, Mei-Jie
    Zhong, Xiaobo
    Huang, Jiaxing
    Dispenzieri, Angela
    Abidi, Muneer H.
    Bird, Jennifer M.
    Freytes, Cesar O.
    Gale, Robert Peter
    Kindwall-Keller, Tamila L.
    Kyle, Robert A.
    Landsburg, Daniel J.
    Lazarus, Hillard M.
    Munker, Reinhold
    Roy, Vivek
    Sharma, Manish
    Vogl, Dan T.
    Wirk, Baldeep
    Hari, Parameswaran N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : 335 - 341